XML 21 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Equity - USD ($)
$ in Thousands
Total
Common Shares
Additional Paid-in Capital
Treasury Shares
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Noncontrolling Interests
Beginning Balance at Dec. 31, 2021 $ 1,307,704 $ 140 $ 368,595 $ (263) $ 1,194 $ 702,759 $ 235,279
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) 5,950         5,503 447
Other comprehensive income 10,822       10,822    
Amounts reclassified from Accumulated other comprehensive income 1,539       1,539    
Contributions from noncontrolling interests 2,450           2,450
Distributions to noncontrolling interests (9,980)           (9,980)
Stock awards, stock option exercises and other shares issued to employees and directors, net of income tax 4,825 2 7,145 (2,322)    
Dividends declared per common share (6,089)         (6,089)  
Restricted share award dividend equivalents 0   54 320   (374)  
Ending Balance at Mar. 31, 2022 1,317,221 142 375,794 (2,265) 13,555 701,799 228,196
Beginning Balance at Dec. 31, 2022 1,429,769 142 385,248 (15,043) 20,484 807,770 231,168
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income (loss) (59,117)         (14,750) (44,367)
Other comprehensive income (1,884)       (1,884)    
Amounts reclassified from Accumulated other comprehensive income (2,333)       (2,333)    
Distributions to noncontrolling interests (9,980)           (9,980)
Stock awards, stock option exercises and other shares issued to employees and directors, net of income tax (2,544)   (8,087) 5,543      
Purchase of treasury shares (1,671)     (1,671)      
Dividends declared per common share (6,240)         (6,240)  
Restricted share award dividend equivalents 412   607 165   (360)  
Ending Balance at Mar. 31, 2023 $ 1,346,412 $ 142 $ 377,768 $ (11,006) $ 16,267 $ 786,420 $ 176,821